The global retinoids market is on a trajectory of significant expansion, according to a recent report by Future Market Insights. The market, currently valued at US$ 1.5 Billion in 2022, is anticipated to surge to US$ 2.5 Billion by 2032, reflecting a steady Compound Annual Growth Rate (CAGR) of 5.4% over the forecast period.
Dermatologists are increasingly opting for less invasive procedures and topical treatments, steering the demand towards retinoids, renowned for their efficacy in addressing a spectrum of skin concerns. Post-surgery, retinoids emerge as pivotal agents, aligning seamlessly with the escalating preference for natural and organic skincare solutions.
Report of Market as Sample Copy: https://www.futuremarketinsights.com/reports/sample/rep-gb-8060
“The global retinoids industry is experiencing remarkable growth, and Future Market Insights is strategically positioned to leverage this trend,” stated Future Market Insights, Inc. “Our unwavering commitment to delivering cutting-edge dermatological solutions perfectly aligns with the industry’s shift towards less invasive treatments and the escalating demand for natural skincare products.”
One of the driving forces propelling the demand for retinoids is the surge in global cases of acne. Manufacturers are responding by incorporating retinoids into a diverse array of products, spanning moisturizers, wrinkle reducers, sunscreens, nail care products, acne reducers, and nail care creams.
As a leading player in the retinoids market, Future Market Insights remains dedicated to investing in research and development to innovate and expand its product portfolio. The company is steadfast in its mission to provide advanced skincare solutions that cater to the evolving preferences of dermatologists and consumers alike.
Key Takeaways from Retinoids Market:
- North America, led by the US, holds more than 30% of the market share. This could be credited to rising incidences of skin disorders and facial acne over here.
- Europe stands second with Germany leading from the front. It holds more than 10% of the market share. This could be reasoned with enhancements in healthcare infrastructure with growing awareness about appropriate skincare regimen and utilization of retinol and various other ingredients in the cosmetic medications and products.
- Coming to the Asia-Pacific, Japan holds more than 9% of the market share; due to an ever-increasing utilization of retinoids in skin care medication and dermatology. Research states that Japan was home to nearly 3,050 general hospitals as of October 2020. Call to look better irrespective of age is driving adoption of the cosmetic products containing good quantity of retinoids for improving level of collagen in the body.
- Synthetic retinoids overpower conventional ones in terms of pharmacological qualities as they pass through specific RAR (retinoic acid receptors), which are capable of reducing side-effects.
Our Comprehensive Methodology Now: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-8060
Competitive Arena:
- Bausch Health Companies Inc., through its dermatology division “Ortho Dermatologics”, delivered 4 presentations at the Florida Society of Dermatology Physician Assistants (FSDPA). They covered novel clinical data related to SILIQ, DUOBRIL, and JUBLIA injection, along with several encore presentations.
- Differin, the very first consumer acne medication approved by the US FDA and doled out by Galderma Laboratories, L.P., has started getting subjected to an audio and a digital advertising campaign that would translate into strategic partnership with Acast Creative.
- The US FDA, in August 2018, approved once-daily retinoid product termed as “Altreno” floored by Ortho Dermatologics to treat patients aged 9 and above.
What does the Report Cover?
- Future Market Insights offers an exclusive perspective and various real-time insights on the retinoids market in its latest study, presenting historical demand assessment of 2016 – 2021 and projections for 2022 – 2032.
- The research study is based on type (natural retinoids and synthetic retinoids), by application (acne, psoriasis, anti-aging, and likewise), and by distribution channel (hospitals pharmacies, online pharmacies, retail pharmacies, and hypermarkets/supermarkets).
Key Companies Profiled:
- GlaxoSmithKline Inc.
- Mylan Pharmaceuticals Inc.
- Sun Pharmaceutical Industries Ltd.
- Janssen Pharmaceuticals Inc.
- Bausch Health Companies Inc.
- Ortho Dermatologics
Purchase Now to Access: https://www.futuremarketinsights.com/checkout/8060
Key Market Segments Covered in Retinoids Industry Research:
By Type:
- Natural Retinoids
- Synthetic Retinoids
By Application:
- Acne
- Psoriasis
- Anti-aging
- Others
By Distribution Channel:
- Hospitals Pharmacies
- Online Pharmacies
- Retail Pharmacies
- Supermarkets / Hypermarkets
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
